Technetium-99m (99mTc) mercaptoacetyltriglycine: Update on the new 99mTc renal tubular function agent
- 30 April 1992
- journal article
- research article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 22 (2) , 61-73
- https://doi.org/10.1016/s0001-2998(05)80082-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Comparison of Tc-99m MAG3 and Tc-99m DTPA in Renal Transplant Patients with Impaired Renal FunctionClinical Nuclear Medicine, 1990
- 99Tcm-MAG3Nuclear Medicine Communications, 1990
- Radiopharmaceuticals: state of the artEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- An investigation of factors that might influence the radiochemical purity and stability of99mTc-MAG3European Journal of Nuclear Medicine and Molecular Imaging, 1990
- Technetium-99m labeled renal function and imaging agents: III. Synthesis of 99mTc-MAG3 and biodistribution of by-productsInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1988
- Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine)International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988
- Evaluation of iminodiacetic acid derivatives of ortho and meta amino hippuric acid analogs as renal function agentsJournal of Labelled Compounds and Radiopharmaceuticals, 1988
- Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticalsJournal of Medicinal Chemistry, 1986
- A NEW RADIOPHARMACEUTICAL FOR GAMMA CAMERA RENOGRAPHY.Nuclear Medicine Communications, 1983
- Assessment of total and divided renal plasma flow by 123I-hippuran renographyKidney International, 1981